アジェンダ
Bio-IT World Venture, Innovation & Partnering IN-PERSON ONLY
バイオITワールド ベンチャー・イノベーション・提携（対面のみ）
2025年4月3日 米国東部標準時（EDT）
Co-Chair's Welcome Remarks: Investing in Innovation: The Future of Biotech and Drug Discovery
William T. Mayo, Senior Vice President, Research, IT, Bristol Myers Squibb
Optimizing Investment Strategies in Biotech
Stephanie Oestreich, Managing Director, Myeloma Investment Fund of the MMRF
Michelle M. Chen, PhD, Chief Business Officer, InSilico Medicine
Brett B. Cook, Partner, F-Prime Capital
Rana Lonnen, Managing Director, Novartis
Kimberly Nearing, Venture Partner, Investment, BVCF Management Ltd.
Sponsored Presentation (Opportunity Available)
Address the Disconnect between Tech VCs and Biotech
Luba Greenwood, Managing Partner, Binney Street Capital, Dana-Farber Cancer Institute
Cris De Luca, Partner, Sanofi Ventures
Investing in the Future of Drug Discovery: Insights for Impactful Investors
Milind Kamkolkar, Venture Partner, RA Capital
The VC & CEO Relationship, Cultivating Enduring Progress
Scott T. Megaffin, CEO, Adiso Therapeutics
Andrew Hedin, Partner, Bessemer Venture Partners
Claire E. Smith, Partner, SpringTide Ventures
Joanne L. Viney, PhD, Co-Founder & President & CEO, Seismic Therapeutic
Catalyzing Drug Discovery Innovation—The Role of Private Equity and Banks
Jeremy P. Goldberg, Operating Partner, Healthcare, Arsenal Capital Partners
Steve Pagliuca, Chairman, CEO, and Founder, PagsGroup
Rebecca Stevenson, Head, Healthcare Investment Banking, Americas, HSBC
How Ginkgo’s Strategic Pivots Drive Profitability in Biotech: Unlocking the Secret Sauce of Commercialization Success
Barry Canton, PhD, Co-Founder & CTO, Ginkgo BioWorks, Inc.
Chairperson's Remarks: AI: Accelerating the Future of Drug Discovery
Steven Lehmann, Head of Venture & Founder of Portal Stargaze, Venture, Portal Innovations LLC
Investing beyond the Molecule: The Future of Drug Discovery
Derek Lowe, PhD, Director, Chemical Biology & Therapeutics, Novartis BioMedical Research
John J. Keilty, Venture Partner, Third Rock Ventures
Demystifying AI—Real Examples in Drug Development
Bill Fitzgerald, Head, Biotechnology Markets Americas, Google
Pat Lorton, Chief Technology Officer and Chief Operating Officer, Software, Software & Ops, Schroedinger Inc
Woody Sherman, PhD, CIO, Psivant Therapeutics
Ajay S. Yekkirala, PhD, Co-Founder & Senior Vice President, Head of Discovery, Superluminal Medicines, Inc.
No-Nonsense AI—Cutting through the Noise
Anna Marie Wagner, Independent Board Member & Advisor, Corporate Development
Brad Calvin, Co-Founder & CEO, AsedaSciences, Inc.
Molly Gibson, Origination Partner, Flagship Pioneering
Investing in the Future of Drug Discovery: Breakthrough Technologies to Watch
Joe Collura, Director, Co-Founder & CEO, Stealth Mode Biotech
Andrea De Souza, Chief Corporate Development Officer, Qubit Pharmaceuticals
Douglas Selinger, PhD, CEO & Founder, Plex Research Inc.
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。